Novo nordisk enters exclusive negotiations to acquire a controlling stake in biocorp, to be followed by a tender offer on all remaining shares

Novo nordisk has entered into exclusive negotiations with bio jag, biocorp's main shareholder, for the purchase of its entire stake in biocorp, representing 45.3 % of its share capital and 62. 2 % of its theoretical voting rights, at a price of 35.00 euros per share.
NVO Ratings Summary
NVO Quant Ranking